MMRd
Showing 1 - 22 of 22
Epigenetic MMRd in Endometrial carcinomas-a Real World Study
Not yet recruiting
- Endometrial Neoplasms
- (no location specified)
Nov 17, 2022
Endometrial Cancer Trial (Anlotinib + Camrelizumab)
Not yet recruiting
- Endometrial Cancer
- Anlotinib + Camrelizumab
- (no location specified)
Sep 26, 2022
Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))
Recruiting
- Colorectal Neoplasms
- Microsatellite Instability
- temozolomide (induction),
- pembrolizumab (treatment)
-
Milano, Italy
- +3 more
Sep 28, 2022
Immunodeficiency Trial in Charlotte (Infusion of donor lymphocytes)
Terminated
- Immunodeficiency
- Infusion of donor lymphocytes
-
Charlotte, North CarolinaLevine Children's Hospital, Carolinas Medical Center
Apr 20, 2022
Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- XmAb20717 + carboplatin + cabazitaxel
- +2 more
-
Duarte, California
- +9 more
May 24, 2022
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Durvalumab
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 26, 2023
Multiple Myeloma Minimal Residual Disease
Completed
- Multiple Myeloma
- blood samples and bone marrow aspirates will be collected
-
Lille, France
- +2 more
Sep 2, 2022
Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)
Not yet recruiting
- Ovarian Neoplasms
- +5 more
- Dostarlimab
- +4 more
- (no location specified)
Sep 3, 2023
Staging Endometrial caNcer Based on molEcular ClAssification
Recruiting
- Endometrial Cancer
- +2 more
-
Pamplona, Navarra, SpainClinica Universidad de Navarra
Jan 30, 2023
Pancreatic Cancer Trial in Goyang-si
Active, not recruiting
- Pancreatic Cancer
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
Sep 27, 2022
Endometrial Tumors, Endometrial Cancer Trial in Seoul (Nivolumab)
Not yet recruiting
- Endometrial Neoplasms
- Endometrial Cancer
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Mar 21, 2023
Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)
Recruiting
- Adenocarcinoma - GEJ
- Cancer of Esophagus
- Temozolomide
- +3 more
-
Cambridge, Cambridgeshire, United KingdomCambridge University Hospitals NHS Foundation Trust
Oct 6, 2021
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)
Active, not recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Atezolizumab
- +4 more
-
Frankfurt, Germany
- +1 more
Apr 14, 2022
A Retrospective Study on Multiple Classifier Endometrial Cancer
Recruiting
- Uterine Cancer
- Observation only
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Jul 27, 2023
Endometrial Cancer Trial in Vancouver (Treatment de-escalation)
Recruiting
- Endometrial Cancer
- Treatment de-escalation
-
Vancouver, British Columbia, CanadaBC Cancer - Vancouver Centre
Mar 1, 2022
Analysis of miRNA Expression in Endometrial Cancer
Recruiting
- Endometrial Cancer
-
Bologna, Bo, ItalyIRCCS- Azienda Ospedaliera-Universitaria di Bologna
Jul 19, 2022
Endometrial Tumors, Uterine Tumors, Endometrium Cancer Trial in Netherlands (PARP inhibitor and Anti-PD-L1)
Active, not recruiting
- Endometrial Neoplasms
- +2 more
- PARP inhibitor and Anti-PD-L1
-
Amsterdam, Netherlands
- +7 more
Mar 30, 2021
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chapel Hill (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- anti-thymocyte globulin
- +8 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
May 23, 2017
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chapel Hill (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- rabbit anti-thymocyte globulin (ATG)
- +7 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Jun 16, 2017